The normalization of data obtained from hybridization experiments with DNA chips to determine mRNA expression and concentration (gene expression profiling)
Abstract
The normalization of data obtained from hybridization experiments with DNA chips to determine mRNA expression and concentration (gene expression profiling)
is an unsolved problem. Furthermore slight changes in mRNA expression or small numbers of mRNA molecules which may be relevant to disease cannot be detected so far.
We have designed a method to calculate the number of molecules of a single mRNA species in a complex mRNA preparation. The basic concept is the transformation of a quantitative problem into a qualitative problem. Individual molecules pertaining to the same molecular species (IMPSMS) are transformed to a mixture of new different molecular species (DMS) and amplified.
We propose two implementations of the method. The first procedure is based on a method for cloning tagged nucleic acid molecules onto the surface of micro-beads. It should be possible to transform and determine up to 10 6 IMPSMS into new DMS. The second strategy uses multimeric linkers, a method frequently used in DNA computing to assemble random DNA. The second strategy should be easier to implement but is limited to a few hundred IMPSMS.
Introduction
Growth and differentiation of a cell in a tissue is dependent on the expression levels of the genes. While the number and type of genes is usually identical in all cells of an organism, the mRNAs expressed and mRNA expression levels are specific for the cell type and state of differentiation.
RNA is not very stable and therefore, it is transcribed into complementary DNA (cDNA) for analysis. The cDNA concentrations of a large number of genes can be measured in parallel by using an addressable DNA micro-array or DNA chip (chips, 2002) . Thereby the normalization of data obtained from different experiments is a difficult problem.
Currently it is not possible to label and count single mRNA molecules of a molecular species in a complex mixture. The most sensitive fluorescence-based assays for quantitation (e.g. PicoGreen) of nucleic acids in solution still need approximately 25 pg/ml of double-stranded DNA. Since quantitation of nucleic acids needs a sufficiently large quantity of molecules an amplification step using PCR is necessary. Each round of a PCR amplification roughly doubles the number of DNA molecules making a following quantitative analysis difficult.
In this paper we make a theoretical suggestion on how to count the number of individual molecules pertaining to the same molecular species (IMPSMS) in a complex molecular sample. We use the fact that mRNA molecules with different sequences or of different length can be distinguished using standard methods. In other words, using standard biochemical methods it is possible to determine the number of different molecular species (DMS) in a sample. The method we propose relies on the transformation of the quantitative problem (count the number of IMPSMS) into a qualitative problem (detect new DMS). After transformation, the number of new DMS directly corresponds to the number of IMPSMS in the original sample.
We suggest two approaches to generate new DMS from IMPSMS.
• Targeted random labeling of each IMPSMS with an oligonucleotide tag.
• Targeted random addition of a variable number of short oligonucleotide linkers.
The first approach is based on a method for cloning tagged nucleic acid molecules onto the surface of micro-beads (Brenner et al., 2000b) . A tag consists of eight 4mers (blocks). To minimize cross-hybridization between tags and between mRNA molecules and tags, the number of 4mers used is restricted to eight (out of 256). During construction of the tags, one of the eight 4mers is selected for each block. The number of different tags that can be build in this way is approximately 1.6 · 10 7 (Brenner et al., 2000b) .
We suggest to randomly attach a tag to each IMPSMS in order to generate a new DMS. If the number of tags is sufficiently large a unique tag will be attached to each IMPSMS and the number of new DMS is equivalent to the number of IMPSMS in the original sample. Each new DMS is uniquely defined by its tag sequence. In a final step the number of different tag sequences is determined. We consider two methods depending on the expected number of IMPSMS. If the number of required tag sequences is less than 60000, the new DMS molecules are hybridized onto the surface of beads for further DNA-sequencing, using the massively parallel signature sequencing (MPSS) method (Brenner et al., 2000a 
The Method
Nucleic acid molecules with different sequences or of different length can be distinguished using standard biochemical methods (Ausubel et al., 2001; Sambrook et al., 1989) . This observation suggests the following approach for counting the number of molecules of a single molecular species. 
Tag labeling
Oligonucleotides of the same length but with different sequences of base pairs (tags) are used to label the IMPSMS. The tags that are attached to the IMPSMS are selected randomly and independently for each IMPSMS. If the number of tag sequences is sufficiently large, it is very likely that almost every IMPSMS will be combined with a unique tag sequence.
To estimate the expected number of identical tags, let m denote the total number of different tag sequences, and let l denote the (unknown) number of IMPSMS. In the following calculation we assume that the tag sequences are numbered 1 to m and that the IMPSMS are attached to tags with sequences i 1 , i 2 , . . . i l in this order.
The probability that the n-th tag sequence is attached to the j-th IMPSMS is 1/m and the probability that the n-th tag sequence is selected by some IMPSMS is 1 − (1 − 1/m) l . Let X n be an indicator variable for this event, i.e.
l is the expected value of X n and the expected value of the number of different tag sequences X = m n=1 X n is given by (using the fact that
For example, if m = 10 7 , the expected number of identical tag sequences is 5 for 10 4 IMPSMS, and increases to approximately 500 and 50000 for 10 5 and 10 6 IMPSMS, respectively.
Multimeric linker labeling
In this method, multimeric linkers of different lengths are attached to the IMPSMS.
Each multimeric linker consists of a certain number of oligonucleotide linkers (repeats)
followed by an oligonucleotide terminator. New DMS are defined by the number of repeats of the multimeric linkers attached to the IMPSMS.
During the transformation as described in Section 2.4, Case 1, 2, and 3, linker oligonucleotides are added to the IMPSMS (by hybridization) until the hybridization is stopped by a terminator oligonucleotide. The probability that a terminator is selected depends of the ratio p of oligonucleotide terminators in the oligonucleotide linker preparation. The probability, that a sequence of oligonucleotide linkers is ter-minated, is given by p, and the probability that a further linker is added, is given by
The number of repeats is (ideally) described by a geometric distribution, in this case the probability of exactly n repeats is p · q n . To estimate the expected number of different lengths let l denote the (unknown) number of IMPSMS and let m be some upper bound on the number of repeats possible in a multimeric linker. In the following calculation we assume that the IMPSMS are numbered 1 to l and that the multimeric linkers attached to the IMPSMS have lengths i 1 , i 2 , . . . i l in this order. The probability that a multimeric linker of length n is attached to some IMPSMS is 1
Let X be an indicator for this event, i.e.,
l is the expected value of X n and the expected value of the number of different multimeric linker length X = m n=1 X n is given by (using the fact that 1 − x ≤ e −x for x ≤ 1),
Consider a ratio p = 1/300 (expected number of repeats 1/p = 300) and multimeric linker of length up to m = 1200. Then, using the above inequality, the expected number of identical repeats is less than 10 for 100 IMPSMS (10%) and less than 34 for 200 IMPSMS (17%).
We observe that the number of repeats is approximately geometrically distributed (depending on the ratio of oligonucleotide terminators) making short multimeric linkers more likely. In contrast to tag labeling (and Case 4 below), where we assume a uniform distribution, it is therefore more likely that identical linkers will be attached to more than one IMPSMS.
During the transformation as described in Section 2.4 (Case 4) multimeric linkers of different lengths are prepared and then attached to the IMPSMS. As with tag labeling, we assume that the multimeric linkers which are added to the IMPSMS are chosen randomly and independently for each IMPSMS. In this case the probability that the linker attached to an IMPSMS has length n is 1/m, where m is the number of different multimeric linker lengths. To increase the applicability of multimeric linker labeling the number of IMPSMS can be estimated e.g. by a maximum likelihood estimation, from the number of different multimeric linker lengths, or the maximal multimeric linker length detected (Hollas & Schuler, 2002) .
Implementation of tag labeling
The oligonucleotides containing the tag sequences, e.g. 32-mers, can be designed and constructed as described (Brenner et al., 2000b) . A tag is an oligonucleotide and consists of eight 4mers (blocks). In total there are 4 4 = 256 different 4mers from which eight are used to build all the tags. That is, each block of the tags consists of one of the eight selected 4mers. The number of different tags that can be constructed in this way is approximately 1.6 · 10 7 (Brenner et al., 2000b) . Furthermore, the different tags are present in the same quantity.
The tags are used to separate DNA molecules. Therefore, in a solution containing (some) tags and oligonucleotides with reverse complementary tag sequences, each tag should bind only to the oligonucleotide with the reverse complementary tag sequence.
To minimize cross-hybridization, the number of different 4mers of the tags is restricted to eight (Brenner et al., 2000b) . The word design e.g. avoids palindromic 4mers and 4mers with partially identical base pairs sequences.
We now give a description of the individual steps involved in the tag labeling method. To separate the mRNA species of interest from the mRNA pool we use oligonucleotides consisting of the reverse complementary sequence of a part of the mRNA sequence followed by a random tag sequence, a restriction enzyme recognition site (R) and an unique primer binding site (abbreviated as PBS in Fig. 1 ). The 5'-end of the primer binding site is labeled with biotin in order to conjugate paramagnetic streptavidine beads (Bio/Str) to separate the mRNA species from the mRNA pool with a magnet (Fig. 1) .
Now the first strand of a cDNA is synthesized (Fig. 1) . Note that each cDNA contains a tag sequence. Furthermore, with very high probability, the number of different tag sequences will be very close to the number of mRNA molecules of the species under consideration.
Depending on a suitable internal forward primer binding site, a part of the cDNA sequence is amplified by the polymerase chain reaction (PCR). At the 5'-ends of the tags, a unique sequence which is used as binding site for the reverse PCR primers, is located (PBS in Fig. 1 ). After PCR amplification the primer binding site sequence is removed by cutting with a restriction enzyme between the tag and the primer binding site sequences (R) (Fig. 1) .
The PCR products can be hybridized to tagged beads (Brenner et al., 2000b; Brenner et al., 2000a; Tyagi, 2000) , where the sequences attached to the beads are reverse complementary to the tag sequences. After hybridization, the beads loaded with DNA are separated as described (Brenner et al., 2000b) . Then the number of different tag sequences is determined by MPSS (Brenner et al., 2000a) . The MPSS method is able to sequence 20 bp of approximately 60000 sequences attached to beads, respectively.
To bind the adaptors for MPSS, the cDNAs are cut at an internal unique restriction enzyme recognition sequence near the tag sequences.
Currently, the sequencing of a large number of tagged DNAs is only feasible in laboratories with the sophisticated equipment for MPSS (e.g. Lynx Therapeutics). Therefore, an alternative strategy to determine the number of different tag sequences could be the use of DNA chips, which consist of oligonucleotides of the reverse complementary tag sequences. The maximum number of oligonucleotides that can be attached to a chip surface is approximately 50.000 (chips, 2002) . The target for chip hybridization is synthesised by primer extension (Fig. 1) . The target is labeled with a fluorescence dye.
The number of the original mRNA molecules corresponds to the signals generated on the chip surface.
The limit of 20 bp which can be sequenced using the MPSS method restricts the number of tags which can be distinguished to 8 5 = 32768. To extend the method we suggest defined block selection (Fig. 2) . For each block position of the tag we prepare eight columns. In each column the 4mer of one block is defined (Fig. 2) . All tags which contain the reverse complementary 4mer at this position are retained and detected. The detection is either through fluorescently labeled or magnetic beads. The tagged beads of the positive columns are eluted and applied to the next set of columns.
In this set of columns the next block consists of defined 4mers (Fig. 2) . Using this strategy we can use the whole set of 8 8 ≈ 1.6 * 10 7 tags. Estimating the diameter of a bead to 2 µm, the required volume of the column would be ≥ 0.13 µl. Instead of columns the oligonucleotides could be covalently attached to poly-acrylamide gels (Braich et al., 2001; Braich et al., 2002) . Separation could also be done in micro-flow reactors (McCaskill, 2001 ).
Implementation of multimeric linker labeling
The second approach uses the fact that the length of DNA molecules can be determined. In fact, measuring the length of DNA molecules by gel electrophoresis is the basis for standard DNA sequencing. Using available kits, it is possible to distinguish approximately 1000 different lengths in one run. Therefore this approach should be easier to implement but is limited to determine the number of a few hundred mRNA molecules. We observe that the multimeric linker labeling method codes the number of IMPSMS in unary, i.e. in the number of different lengths of the multimeric linker.
In contrast, the tag labeling method described in the previous section uses a four letter alphabet to count the number of IMPSMS.
The self assembly of DNA is used to built multimeric linkers of different length.
Consider oligonucleotides P and Q such that the sequence of P at the 5' end is reverse complementary to the sequence of Q at the 3' end and the sequence of P at the 3' end is reverse complementary to the sequence of Q at the 5' end. (For example P = CTAGAACC and Q = CTAGGGTT see Fig. 3B and C.) If P and Q are put into solution oligonucleotides P and Q will hybridize (at the 5' and 3' ends) and build chains of P 's and Q's of different length. It is interesting to note, that self assembly of DNA is used in DNA Computing to generate a set of all possible combinations of different oligonucleotide sequences (see e.g. (Adleman, 1994) ). Here, we use identical oligonucleotides for multimerization.
We now give a description of the individual steps involved in the multimeric linker labeling method. The first strand of the cDNA is synthesized by using an oligonucleotide whose sequence is reverse complementary to the sequence of the mRNA of interest. At the 5'end of this oligonucleotide a recognition site of a restriction endonu-clease (e.g. BamH1) is attached (Fig. 3A) . A double stranded cDNA is synthesized and cleaved with the restriction endonuclease (e.g. BamH1) according to standard protocols (Ausubel et al., 2001) as outlined in Fig. 3A .
Linkers consist of the recognition site of BamH1 and a suitable short sequence which minimizes cross-hybridization (Fig. 2B) . Linkers are mixed with a certain ratio of stop sequences (Fig. 2B) while added to the cDNAs in order to hybridize to the sticky BamH1 ends (Fig. 2C) . The stop linker will terminate linker ligation at every possible position in analogy to the dideoxy-method of DNA sequence analysis (Sanger et al., 1977) . Again we assume that the linker ligation is a random process.
In the final step the multimeric linkers are ligated with T4 DNA ligase to the cDNA and with each other. Each cDNA molecule should now have attached a multimeric linker of a particular length (Fig. 2C) . The cDNAs are amplified by PCR and the number of different multimeric linkers is determined by DNA length analysis using gel electrophoresis with appropriate DNA size markers.
In practise, linker ligation can be carried out following several alternative protocols.
1. The double stranded cDNA with sticky ends is mixed together with linker and terminator oligonucleotides. Linker and terminator oligonucleotides are at a defined ratio.
2. First the linker oligonucleotides are added and ligated to the cDNA preparation.
Terminator oligonucleotides are added and ligated after a defined time interval.
3. First linker and terminator oligonucleotides are mixed at a defined ratio and ligated. The products are then added to the cDNA preparation and ligated.
4. A similar strategy is to chemically synthesise DNA oligonucleotides of different lengths and hybridize them. One strand will yield a BamH1 sticky end. The advantage would be that the length of the oligonucleotides can differ in only 1 bp. The synthetic molecules are then added to the cDNA preparation and ligated.
We observe that the length of a new DMS, i.e., the number of linker oligonucleotides of a multimeric linker molecule, is geometrically distributed in Case 1, Case 2, and Case 3, and uniformly distributed in Case 4. The probability of the geometric distribution is determined by the ratio of linker and terminator oligonucleotides.
Discussion
The tubulin, GAPDH, histones or other so called house keeping genes (Hsiao et al., 2001 ).
These mRNAs are present in relatively high amounts and are expressed with minimal fluctuations. When this is established, one could start to determine the number of tissue-or tumor-specific mRNAs, which usually show a lower expression. In some cases, the number of mRNA molecules could also be estimated by competitive PCR (Wang et al., 1989; Gilliland et al., 1990) . Our protocol may also be established using such data.
In principle, our strategies provide a very accurate method for measuring the expression of defined candidate genes involved in diseases. Expression of these genes could be determined in parallel to large scale gene expression profiling. For instance, low amounts of mRNAs expressed by viruses could be detected at earlier stages of infection.
In many diseases which could be diagnosed according to gene activity, i. e. the mRNA expression pattern, the problem is that only very little tissue amounts are available. In tumor surgery (e.g. brain tumors) it is often not possible to obtain enough control tissue. Our method could be suitable to detect changes in mRNA levels in total RNA or mRNA preparations which are derived of only a few cells. In addition, information about the exact number of IMPSMS is provided. In molecular diagnosis, the mRNAs under investigation have to be compared to the number of molecules of control mRNAs of housekeeping genes which are supposed not to be influenced by the disease.
A further application is to determine the number of a certain mRNA ( Beads are separated through eight rounds of selection. In the first selection the beads are sequentially run over the eight columns with a defined 4mer at block position 1.
The matrix for the oligonucleotides in the columns is a polysaccharide (e.g. sepharose).
The temperature is selected in order that 100% matches are captured but beads containing oligonucleotides with one or more mismatches are in the flow through. Elution is above the melting temperature of the oligonucleotides. The following selection rounds are only done for positive samples of the previous selection round. The beads contain either a fluorescence or a magnetic label to allow detection. 
